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cientists have known about biases 
in single observations for centuries. 
A wealth of empirical evidence 
amassed across many disciplines 
tells us that single studies can be 
biased, are often seriously methodologically 
fl awed and highly time and context dependent, 
and have fi ndings that are likely to be 
misinterpreted and misrepresented (sometimes 
by the authors themselves). Increasingly it is 
accepted that decisions should not be based 
on the fi ndings from single primary studies 
but rather informed by actionable messages 
derived from synthesised evidence based 
on systematic reviews. Over the past decade 
there has been substantial public funding of 
synthesised evidence and guidance to support 
healthcare decision making. In the United 
Kingdom this investment has been described 
as NHS research and development’s main 
contribution to the global science base.
Despite this investment the evidence 
indicates that although the transfer of research 
knowledge is possible its success can be 
variable. There is now renewed interest 
and emphasis on the gaps between research 
and policy and practice, nationally and 
internationally. This emphasis on bridging the 
gap may be viewed as encouragement to strive 
even harder to promote research to ever wider 
audiences—to be seen to be providing a return 
on investment. But it may be worth pausing 
to consider the benefits and costs of such 
activity and ask why the research community 
continues to place such emphasis on the 
promotion of the primary research study.
The emphasis on the single 
study drives submissions to the 
current UK Research Assessment 
Exercise (RAE). Although 
the RAE does recognise 
that original research may 
include systematic reviews, 
the practice of many academic 
organisations is to prioritise—or 
sometimes only include—primary 
research, under the assumption that 
systematic reviews are not relevant or are less 
important.
Most bodies that commission research also 
expect and demand some commitment or 
effort on the part of grant holders, regardless 
of study design, to disseminate in ways 
that go beyond the traditional medium of 
academic publication. The emphasis is on 
communicating and interacting with wider 
policy and health service audiences in ways 
that will facilitate uptake of research results in 
practice and policy. The rationale, appropriate 
conditions, and contexts for such interactions 
are rarely provided by the funding body, and 
nor is any acknowledgment that evidence set 
in context is of most value to decision makers.
Some medical journals encourage 
researchers to discuss their findings in the 
context of the existing and relevant evidence 
base. But research suggests little progress has 
been made by researchers and journal editors 
in ensuring that single studies are set in context 
or that the consolidated standards of reporting 
trials (CONSORT) recommendation is 
adhered to. Furthermore, every week journals 
issue press releases aimed at generating 
publicity for the most “newsworthy” studies 
and for the journal itself. There is some 
evidence that primary research studies are 
proportionally more likely to be included in 
press releases than systematic reviews.
The emphasis on newsworthy research 
promotion is not restricted to academic 
journals. Universities, research centres, 
funders, and councils all use the media to 
promote research. Rather than representing 
an attempt to explain new findings in the 
context of existing knowledge, media strategies 
are used to build the corporate image of the 
host institution or funder, for agenda setting, 
and to attract and secure future funding. 
Using the media to promote the 
results of primary research can 
have harms and can erode trust 
in and understanding of science generally. 
More often than not the latest breakthroughs, 
miracle cures, and wonder drugs are based on 
single studies. Often buried within the press 
release are notes of caution and suggestions 
that further research is needed and that a 
viable treatment is actually years away. We 
all know that these disclaimers are rarely if 
ever reported prominently; and the research 
community, while quick to raise concerns 
about media accuracy, rarely questions the 
appropriateness of media dissemination.
The renewed interest and emphasis on the 
knowledge translation is to be welcomed. But 
more than ever there is a need for researchers, 
especially those conducting primary research, 
to consider carefully the costs and benefits of 
dissemination. Not every study needs wide 
dissemination. Most primary research needs to 
be set in context, verified, and built on, moving 
the field forward incrementally before it can 
then have wider application. Rather than being 
encouraged to find ever more creative ways to 
get research noticed, funders should encourage 
researchers to show they have considered 
carefully the appropriateness of their plans for 
dissemination.
Medical journals can do more to ensure 
that researchers actually do discuss the 
findings of primary studies in the context of 
the existing and relevant evidence base. The 
Academy of Medical Sciences in London has 
recently argued that researchers, funders, and 
institutions should take greater responsibility 
for the accurate communication of non-
experimental research. In truth, the research 
community as a whole needs to be more 
circumspect when it comes to the active 
promotion of primary research. Although all 
research has an audience, and should be made 
accessible, not all research can or should have 
an impact on practice or policy.
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